Man Group plc

Position in ZYME — Zymeworks Inc.

CIK 1637460 LONDON, X0

Position in ZYME

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,754,845

+$2,771,723 QoQ

Shares Held

189,890

+152.1% QoQ

Ownership

0.260%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 75% Shared 0% None 25%

Healthcare · as of Mar 31, 2026

Man Group plc holds $1,080,100,046 across 125 Biotechnology names. ZYME ranks #30 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	315,212	$243,545,399
2	VRTX	Vertex Pharmaceuticals Inc / Ma	236,798	$105,739,778
3	INCY	Incyte Corp	930,171	$87,547,693
4	ALNY	Alnylam Pharmaceuticals, Inc.	232,369	$76,883,931
5	ONC	BeOne Medicines Ltd.	241,922	$71,843,576
6	APLS	Apellis Pharmaceuticals, Inc.	915,689	$36,838,167
7	RVMD	Revolution Medicines, Inc.	275,270	$26,770,006
8	JAZZ	Jazz Pharmaceuticals plc	135,212	$25,561,828

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,754,845	189,890	+152.1%	Shares	Defined	2026-05-15
2025-12-31	$1,983,122	75,318	-52.5%	Shares	Defined	2026-02-17
2025-09-30	$2,709,161	158,616	+348.0%	Shares	Defined	2025-11-14
2025-06-30	$444,345	35,406	+226.1%	Shares	Defined	2025-08-14
2025-03-31	$129,330	10,859	-72.6%	Shares	Defined	2025-05-15
2024-03-31	$416,413	39,583	-7.4%	Shares	Defined	2024-05-15
2023-12-31	$444,369	42,769	+70.6%	Shares	Defined	2024-02-14
2023-09-30	$158,962	25,073	+11.4%	Principal	Defined	2023-11-14
2023-06-30	$194,520	22,514	+81.3%	Shares	Defined	2023-08-14
2023-03-31	$112,258	12,418	-32.1%	Principal	Defined	2023-05-15
2022-12-31	$143,751	18,289	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.